daisymiller

Gefitinib is a groundbreaking targeted therapy used primarily for non-small cell lung cancer (NSCLC). As an EGFR (epidermal growth factor receptor) inhibitor, it works by blocking cancer cell growth, making it a preferred treatment for patients with EGFR mutations. Unlike traditional chemotherapy, Gefitinib specifically targets cancer cells, reducing side effects and improving patient outcomes. With its increasing demand, Gefitinib manufacturer play a crucial role in ensuring global accessibility to this life-saving drug. Countries like India and China are major suppliers, making affordab